F2RL3 and coronary artery disorder: These altered DNA methylation patterns in the blood-based F2RL3 could be detected in minor to medium cardiac function impairment (NYHA I&II CHD cases) and became even more aberrant in the patients with advanced cardiac function impairment (NYHA III&IV CHD cases).